# FDA Inspection 633616 - Biomat USA, Inc. - November 20, 2009

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4633d653-e493-4f13-b8da-c485b0a5b92e
Source feed: FDA_Inspections

> FDA Inspection 633616 for Biomat USA, Inc. on November 20, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 633616
- Company Name: Biomat USA, Inc.
- Inspection Date: 2009-11-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122741 - 2020-03-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/26550312-2e42-44bc-a40a-9a39ed1e4872)
- [FDA Inspection 1028042 - 2017-09-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3baeb269-4621-4960-9253-2bdca737d904)
- [FDA Inspection 951328 - 2015-10-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8db8a86c-f8ad-48c3-b23e-67938c5e0847)
- [FDA Inspection 862866 - 2014-01-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/45caabf2-44fe-4d1d-a882-a5467224a150)
- [FDA Inspection 773758 - 2012-03-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/359f10e7-3241-4aae-bdd5-621f468d820a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/4f82b2fd-3b99-4e1f-9d39-35fc75cf9257

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d